跳至主要内容
临床试验/NCT02021760
NCT02021760已完成不适用

Reduction in Infarct Size by Remote Per-postconditioning in Patients With ST-elevation Myocardial Infarction in Stockholm (RECOND)

John Pernow4 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2013年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
4
主要终点
Myocardial infarct size expressed as a percentage of the myocardium at risk determined by Cardiac Magnetic Resonance

研究概览

简要总结

  • Trial objective: To test the hypothesis that remote per-postconditioning in connection with primary PCI will reduce myocardial infarct size patients with STEMI.
  • Trial Design: Placebo controlled randomized study with parallel groups
  • Primary Endpoint: Myocardial infarct size expressed as a percentage of the myocardium at risk determined by Cardiac Magnetic Resonance (CMR) day 4-7
  • Efficacy Parameters: Myocardial infarct size expressed as a percentage to the myocardium at risk determined by CMR at 6 months.
  • Global left ventricular function determined by left ventricular ejection fraction determined by CMR.
  • Microvascular obstruction determined by CMR day 4-7. Quantified ECV (extracellular volume) in left ventricular as myocardium at risk day 4-7 and remodelling parameters day 180.
  • Safety Parameters: Major adverse cardiovascular events.

详细描述

See above. 3 patients left to include.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient planned for primary PCI.
  • Chest pain indicating myocardial ischemia with a duration >30 minutes and < 6 hours prior to randomization.
  • ST elevations >0.1 mV (>0.2 mV in V2-V3) in > two contiguous leads in V1-V
  • Informed consent.

排除标准

  • Previous myocardial infarction based on medical history or Q-wave on ECG in other area
  • Left Bundle Branch Block on ECG.
  • Previous CABG
  • Cardiac arrest
  • Any contraindication for CMR.
  • Clinical symptoms of claudication
  • Treatment with glibenclamide or cyclosporine on admission.
  • Any condition that may interfere with the possibility for the patient to comply with or complete the study protocol.

结局指标

主要结局

Myocardial infarct size expressed as a percentage of the myocardium at risk determined by Cardiac Magnetic Resonance

时间窗: 4-7 days following index event

次要结局

  • Myocardial infarct size expressed as a percentage to the myocardium at risk determined by Cardiac Magnetic Resonance(6 months following index event)

研究者

发起方
John Pernow
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

John Pernow

Professor

Karolinska Institutet

研究点 (4)

Loading locations...

相似试验